SEC 13F Intelligence

Notis-Mcconarty Edward / ABT

Notis-Mcconarty Edward’s Abbott Laboratories Position

Does Notis-Mcconarty Edward own Abbott Laboratories (ABT)? Yes — 59.6K shares worth $6M (+3.04% of its 13F portfolio) as of Q1 2026, down from 60.5K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
59.6K
% of Portfolio
+3.04%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $8MQ2 ’19: $8MQ3 ’19: $8MQ4 ’19: $8MQ4 ’19Q1 ’20: $7MQ2 ’20: $8MQ3 ’20: $9MQ4 ’20: $9MQ4 ’20Q1 ’21: $10MQ2 ’21: $9MQ3 ’21: $10MQ4 ’21: $12MQ4 ’21Q1 ’22: $10MQ2 ’22: $9MQ3 ’22: $8MQ4 ’22: $9MQ4 ’22Q1 ’23: $8MQ2 ’23: $9MQ3 ’23: $8MQ4 ’23: $9MQ4 ’23Q1 ’24: $9MQ2 ’24: $8MQ3 ’24: $7MQ4 ’24: $7MQ4 ’24Q1 ’25: $8MQ2 ’25: $8MQ3 ’25: $8MQ4 ’25: $8MQ4 ’25Q1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202659.6K$6M+3.04%
Q4 202560.5K$8M+3.52%
Q3 202560.4K$8M+3.76%
Q2 202560.5K$8M+4.01%
Q1 202561.0K$8M+4.16%
Q4 202460.8K$7M+3.33%
Q3 202462.5K$7M+3.23%
Q2 202473.4K$8M+3.00%
Q1 202475.0K$9M+3.37%
Q4 202380.6K$9M+3.54%
Q3 202380.6K$8M+3.18%
Q2 202380.9K$9M+3.36%
Q1 202381.6K$8M+3.29%
Q4 202281.6K$9M+3.73%
Q3 202281.6K$8M+3.53%
Q2 202281.7K$9M+3.70%
Q1 202281.5K$10M+3.44%
Q4 202182.5K$12M+3.87%
Q3 202183.2K$10M+3.60%
Q2 202181.7K$9M+3.51%
Q1 202182.4K$10M+3.84%
Q4 202081.8K$9M+3.64%
Q3 202084.2K$9M+4.03%
Q2 202086.0K$8M+3.67%
Q1 202087.7K$7M+3.83%
Q4 201989.8K$8M+3.47%
Q3 201990.8K$8M+3.57%
Q2 201992.6K$8M+3.68%
Q1 201995.2K$8M+3.68%
Q4 201896.1K$7M+3.83%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Notis-Mcconarty Edward’s full portfolio or all institutional holders of ABT.